Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Diabetes is an important risk factor of coronary atherosclerosis, and it's well known that
platelets of diabetic patients are hyper reactive and so resistant to common antithrombotic
therapy. Moreover, in diabetic patients platelets are characterized by high turnover that is
responsible of lack of protection by cardioaspirin at common dosage. The aim of our study is
to asses the efficacy of different doses of aspirin in diabetic patients with acute coronary
syndrome.